Takehiro Yamada
Impact in
-
- Antibiotic Use and Resistance
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Surgery 18
- Peripheral Artery Disease Management 12
- Pharmacology 18
- Inflammatory mediators and NSAID effects 9
- Antibiotics Pharmacokinetics and Efficacy 7
- Pharmacy and Medical Practices 7
- Co-authors
- Ken Iseki (39 shared papers)Masaki Kobayashi (28 shared papers)Takayuki Fujino (9 shared papers)Fumitaka Ushikubi (9 shared papers)Shuh Narumiya (9 shared papers)Akiyoshi Hara (9 shared papers)Osamu Takahata (8 shared papers)Koh-ichi Yuhki (6 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (7 papers)Journal of Chromatography B (6 papers)Circulation (4 papers)Journal of Atherosclerosis and Thrombosis (3 papers)Supportive Care in Cancer (3 papers)
- Partner nations
- JapanUnited StatesNew Zealand
In The Last Decade
Takehiro Yamada
110 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 136
- Applied Microbiology and Biotechnology 105
- Biochemistry 242
- Pharmacology 417
- Molecular Medicine 107
- Cardiology and Cardiovascular Medicine 222
Countries citing papers authored by Takehiro Yamada
This map shows the geographic impact of Takehiro Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Yamada more than expected).
Fields of papers citing papers by Takehiro Yamada
This network shows the impact of papers produced by Takehiro Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Yamada. The network helps show where Takehiro Yamada may publish in the future.
Co-authors
The 25 scholars most cited alongside Takehiro Yamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 166 | |
| 2 | 2004 | 146 | |
| 3 | 2005 | 123 | |
| 4 | 1987 | 103 | |
| 5 | 2013 | 95 | |
| 6 | 2005 | 86 | |
| 7 | 2004 | 83 | |
| 8 | 1998 | 54 | |
| 9 | 2006 | 43 | |
| 10 | 2003 | 42 | |
| 11 | 2018 | 41 | |
| 12 | 2017 | 40 | |
| 13 | 2013 | 38 | |
| 14 | 2010 | 37 | |
| 15 | 2017 | 35 | |
| 16 | 2016 | 35 | |
| 17 | 2017 | 34 | |
| 18 | 2010 | 32 | |
| 19 | 2001 | 31 | |
| 20 | 2012 | 29 |
About Takehiro Yamada
Takehiro Yamada is a scholar working on Surgery, Pharmacology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology, having authored 122 papers that have together received 2.0k indexed citations. Recurring topics across this work include Peripheral Artery Disease Management (12 papers), Inflammatory mediators and NSAID effects (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmacy and Medical Practices (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Cardiac electrophysiology and arrhythmias (5 papers), Antibiotic Resistance in Bacteria (5 papers) and Antibiotic Use and Resistance (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (105 citations), Biochemistry (242 citations), Pharmacology (417 citations), Molecular Medicine (107 citations) and Cardiology and Cardiovascular Medicine (222 citations). Takehiro Yamada has collaborated with scholars based in Japan, United States and New Zealand. Frequent co-authors include Ken Iseki, Masaki Kobayashi, Takayuki Fujino, Fumitaka Ushikubi, Shuh Narumiya, Akiyoshi Hara, Osamu Takahata, Koh-ichi Yuhki, Kōji Takayama and Chun-Yang Xiao. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Journal of Chromatography B, Circulation, Journal of Atherosclerosis and Thrombosis and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.